| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | HASTINGS DAVID C Chief Financial Officer | Sale | -22,183 | -12.19%159,724 | $3.28 | $72,827 | View SEC filing | |
| 2025-02-05 | Sims Karen Chief Medical Officer | Sale | -19,348 | -15.41%106,194 | $3.28 | $63,519 | View SEC filing | |
| 2025-02-05 | McElhaugh Michael J. Interim President & CEO | Sale | -23,790 | -1.58%1,481,003 | $3.28 | $78,103 | View SEC filing | |
| 2025-02-05 | Naftzger J. Christopher General Counsel and CCO | Sale | -11,333 | -11.61%86,244 | $3.28 | $37,206 | View SEC filing | |
| 2024-08-16 | MANCHESTER KEITH S Director | Sale | -8,846 | -16.11%46,069 | $3.69 | $32,637 | View SEC filing | |
| 2024-02-05 | Sims Karen Chief Medical Officer | Sale | -4,358 | -3.35%125,542 | $2.31 | $10,078 | View SEC filing | |
| 2024-02-05 | HASTINGS DAVID C Chief Financial Officer | Sale | -9,593 | -5.01%181,907 | $2.31 | $22,184 | View SEC filing | |
| 2024-02-05 | Sofia Michael J. Chief Scientific Officer | Sale | -9,982 | -0.67%1,485,121 | $2.31 | $23,083 | View SEC filing | |
| 2024-02-05 | McElhaugh Michael J. Interim President & CEO | Sale | -10,164 | -0.67%1,504,793 | $2.31 | $23,504 | View SEC filing | |
| 2021-12-03 | Sofia Michael J. Chief Scientific Officer | Sale | -200,000 | -13.30%1,303,403 | $5.09 | $1,018,000 | View SEC filing | |
| 2021-02-10 | McElhaugh Michael J. Chief Business Officer | Sale | -20,000 | -1.51%1,307,457 | $5.00 | $100,000 | View SEC filing | |
| 2020-12-16 | McElhaugh Michael J. Chief Business Officer | Sale | -40,000 | -2.93%1,327,457 | $5.00 | $200,032 | View SEC filing | |
| 2020-07-27 | McElhaugh Michael J. Chief Business Officer | Sale | -20,000 | -1.44%1,367,457 | $5.01 | $100,200 | View SEC filing | |
| 2018-08-15 | Sofia Michael J. Chief Scientific Officer | Sale | -4,250 | -2.48%167,162 | $9.51 | $40,436 | View SEC filing | |
| 2018-08-14 | Sofia Michael J. Chief Scientific Officer | Sale | -4,250 | -0.28%1,499,153 | $9.51 | $40,436 | View SEC filing | |
| 2018-07-13 | Sofia Michael J. Chief Scientific Officer | Sale | -10,000 | -0.66%1,503,403 | $10.00 | $100,000 | View SEC filing | |
| 2018-07-10 | Sofia Michael J. Chief Scientific Officer | Sale | -20,000 | -1.30%1,513,403 | $8.68 | $173,560 | View SEC filing | |
| 2018-07-06 | Sofia Michael J. Chief Scientific Officer | Sale | -20,000 | -1.29%1,533,403 | $8.20 | $164,000 | View SEC filing | |
| 2018-01-16 | SoftBank Vision Fund L.P. 10% Owner | Purchase | +13,025,536 | +132.80%22,833,921.542 | $5.10 | $66,400,000 | View SEC filing | |
| 2018-01-16 | Dexxon Holdings Ltd. 10% Owner | Purchase | +13,025,536 | +132.80%22,833,921.542 | $5.10 | $66,400,000 | View SEC filing | |
| 2018-01-16 | Lo Andrew 10% Owner | Purchase | +13,025,536 | +132.80%22,833,921.542 | $5.10 | $66,400,000 | View SEC filing | |
| 2018-01-16 | Roivant Sciences Ltd. 10% Owner | Purchase | +664,000 | +132.80%1,164,000 | $100.00 | $66,400,000 | View SEC filing | |
| 2018-01-16 | Machado Patrick 10% Owner | Purchase | +13,025,536 | +132.80%22,833,921.542 | $5.10 | $66,400,000 | View SEC filing | |
| 2018-01-16 | VIKING GLOBAL INVESTORS LP 10% Owner | Purchase | +13,025,536 | +132.80%22,833,921.542 | $5.10 | $66,400,000 | View SEC filing | |
| 2018-01-16 | Viking Global Equities LP 10% Owner | Purchase | +13,025,536 | +132.80%22,833,921.542 | $5.10 | $66,400,000 | View SEC filing |
1-25 of 37
